Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: insights chronic disease healthcare for elderly
… Comparison Challenge on Cost-Effectiveness Models in Alz Disease and Related Dementias William L Herring, PhD … Health Economics Transcript As disease-modifying therapies for Alzheimer’s disease, or AD, enter the market, economic … We then compared the model results to generate insights into the impact of these modeling choices on …
… Why Choose RTI Health Solutions for Healthcare Consulting? RTI Health Solutions is the place …
… Outcomes Research (HEOR) Strategy Plans and Gap Analyses for a Treatment Targeting Multiple Rare Diseases OPPORTUNITY … 2 and 3 clinical trials for the treatment of numerous rare disease indications (chronic inflammatory demyelinating polyneuropathy (CIDP), …
… adverse events, and the overall survival of patients with chronic lymphocytic leukemia (CLL) and mantle cell lymphoma … outcomes (direct medical costs to both patients and the healthcare system). Adverse events from cancer treatments … The annual economic burden of adverse events and other disease-related medical costs of CLL alone in the United …
… and Consumers OPPORTUNITY Our client needed to understand healthcare professionals (HCP) knowledge, attitudes, and practices for multiple vaccines currently on the market, and consumers’ knowledge, attitudes, and perceptions of a disease for which there is currently not a vaccine available. …
… our clients on projects to research gastrointestinal (GI) disease, GI treatment, and complications and comorbidities of GI disease. Our experience includes: Celiac disease Chronic idiopathic constipation Crohn’s disease … (GI) market and to develop and gain market access for products to treat GI diseases and complications arising …
… strategies and value messages, MCDA can be used to gain insights at each stage of your product’s lifecycle. We can … . Additionally, the decision process can be simulated for each target market or country. With access to clinical …
… the clinical and economic evidence they will expect to see for your product to gain reimbursement. Let us help you … and therapeutics committees—to gain the most useful insights about your product, its competitors, and the current … boards to address negative coverage policies in the US and disease area concerns worldwide. To get a well-rounded view …
… treatment, and complications and comorbidities of CNS disease. Our experience includes: Alzheimer’s Diabetic … Multiple sclerosis Overactive bladder Pain (acute and chronic) Parkinson’s Restless legs syndrome Sleep Stroke … in the CNS market and to develop and gain market access for products to treat CNS diseases and complications arising …
… at NASEM About Target Trial Emulation to Evaluate Drugs for Rare Diseases Share on: Tuesday, February 6 - Wednesday, … used to evaluate the safety and efficacy of drugs for rare diseases or conditions. NASEM has invited Xabier … Martinez, MD, PhD, to present at an upcoming meeting for the study. During the Novel Methodologies session, Dr. …